Skip to main navigation Skip to search Skip to main content

Circulating tumor cells: Evolving evidence and future challenges

  • Efrat Dotan
  • , Steven J. Cohen
  • , Katherine R. Alpaugh
  • , Neal J. Meropol
  • Fox Chase Cancer Center
  • Case Western Reserve University

Research output: Contribution to journalReview articlepeer-review

71 Scopus citations

Abstract

Circulating tumor cells (CTCs) are rare malignant cells found in the peripheral blood that originate from the primary tumor or metastatic sites. New techniques have been developed to isolate and characterize these cells. CTC enumeration has been incorporated into different fields of oncology as a prognostic marker, a tool to monitor therapy response, and a method to understand basic tumor characteristics. This review covers the different techniques available for isolation of CTCs, the clinical utility of CTCs in breast, prostate, and colon cancer, and future directions in this field.

Original languageEnglish
Pages (from-to)1070-1082
Number of pages13
JournalOncologist
Volume14
Issue number11
DOIs
StatePublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast cancer
  • Circulating tumor cells
  • Colon cancer
  • Prostate cancer

Fingerprint

Dive into the research topics of 'Circulating tumor cells: Evolving evidence and future challenges'. Together they form a unique fingerprint.

Cite this